News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,401 Results
Type
Article (70505)
Company Profile (233)
Press Release (646645)
Multimedia
Podcasts (113)
Webinars (23)
Section
Business (188670)
Career Advice (2848)
Deals (33759)
Drug Delivery (127)
Drug Development (83386)
Employer Resources (160)
FDA (17178)
Job Trends (15099)
News (332658)
Policy (33844)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2943)
Academic (1)
Accelerated approval (41)
Adcomms (32)
Allergies (157)
Alliances (51583)
ALS (185)
Alzheimer's disease (1766)
Antibody-drug conjugate (ADC) (373)
Approvals (17402)
Artificial intelligence (584)
Autoimmune disease (182)
Automation (44)
Bankruptcy (344)
Best Places to Work (11660)
BIOSECURE Act (21)
Biosimilars (196)
Biotechnology (155)
Bladder cancer (176)
Brain cancer (68)
Breast cancer (697)
Cancer (5342)
Cardiovascular disease (434)
Career advice (2413)
Career pathing (43)
CAR-T (311)
CDC (59)
Celiac Disease (1)
Cell therapy (824)
Cervical cancer (41)
Clinical research (70894)
Collaboration (1903)
Company closure (4)
Compensation (771)
Complete response letters (77)
COVID-19 (2867)
CRISPR (104)
C-suite (915)
Cystic fibrosis (155)
Data (6550)
Decentralized trials (2)
Denatured (31)
Depression (153)
Diabetes (508)
Diagnostics (6947)
Digital health (45)
Diversity (11)
Diversity, equity & inclusion (39)
Drug discovery (285)
Drug pricing (207)
Drug shortages (28)
Duchenne muscular dystrophy (244)
Earnings (73447)
Editorial (66)
Employer branding (20)
Employer resources (146)
Events (100050)
Executive appointments (1019)
FDA (20493)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1582)
Gene editing (213)
Generative AI (57)
Gene therapy (651)
GLP-1 (1023)
Government (4978)
Grass and pollen (8)
Guidances (386)
Healthcare (19046)
HIV (71)
Huntington's disease (45)
IgA nephropathy (85)
Immunology and inflammation (257)
Immuno-oncology (75)
Indications (135)
Infectious disease (3167)
Inflammatory bowel disease (202)
Inflation Reduction Act (13)
Influenza (127)
Intellectual property (264)
Interviews (537)
IPO (15537)
IRA (50)
Job creations (3785)
Job search strategy (1981)
JPM (67)
Kidney cancer (19)
Labor market (80)
Layoffs (559)
Leadership (40)
Legal (7563)
Liver cancer (102)
Longevity (19)
Lung cancer (717)
Lymphoma (393)
Machine learning (48)
Management (56)
Manufacturing (844)
MASH (178)
Medical device (12744)
Medtech (12800)
Mergers & acquisitions (19292)
Metabolic disorders (1322)
mRNA (185)
Multiple sclerosis (176)
NASH (20)
Neurodegenerative disease (358)
Neuropsychiatric disorders (91)
Neuroscience (3097)
Neurotech (1)
NextGen: Class of 2026 (6659)
Non-profit (4970)
Now hiring (58)
Obesity (611)
Opinion (321)
Ovarian cancer (176)
Pain (219)
Pancreatic cancer (253)
Parkinson's disease (305)
Partnered (37)
Patents (526)
Patient recruitment (549)
Peanut (62)
People (57463)
Pharmaceutical (53)
Pharmacy benefit managers (32)
Phase 1 (22194)
Phase 2 (30950)
Phase 3 (23179)
Pipeline (6046)
Policy (321)
Postmarket research (2863)
Preclinical (9835)
Press Release (68)
Prostate cancer (273)
Psychedelics (54)
Radiopharmaceuticals (315)
Rare diseases (967)
Real estate (6067)
Recruiting (71)
Regulatory (26150)
Reports (38)
Research institute (2710)
Resumes & cover letters (456)
Rett syndrome (31)
RNA editing (16)
RSV (84)
Schizophrenia (157)
Series A (262)
Series B (194)
Service/supplier (10)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (47)
Startups (3557)
State (2)
Stomach cancer (21)
Supply chain (108)
Tariffs (90)
The Weekly (81)
Vaccines (1109)
Venture capital (93)
Weight loss (401)
Women's health (100)
Worklife (21)
Date
Today (147)
Last 7 days (697)
Last 30 days (2906)
Last 365 days (29533)
2026 (5300)
2025 (29826)
2024 (34395)
2023 (38998)
2022 (49972)
2021 (54271)
2020 (53153)
2019 (46736)
2018 (35616)
2017 (32715)
2016 (32177)
2015 (37475)
2014 (30413)
2013 (27120)
2012 (28094)
2011 (28787)
2010 (27639)
Location
Africa (986)
Alabama (91)
Alaska (6)
Arizona (272)
Arkansas (13)
Asia (44102)
Australia (7750)
California (10973)
Canada (3320)
China (1191)
Colorado (473)
Connecticut (501)
Delaware (311)
Europe (99891)
Florida (1659)
Georgia (342)
Hawaii (3)
Idaho (60)
Illinois (901)
India (75)
Indiana (511)
Iowa (21)
Japan (459)
Kansas (124)
Kentucky (42)
Louisiana (35)
Maine (84)
Maryland (1393)
Massachusetts (7815)
Michigan (330)
Minnesota (582)
Mississippi (5)
Missouri (145)
Montana (36)
Nebraska (28)
Nevada (126)
New Hampshire (76)
New Jersey (3064)
New Mexico (32)
New York (3058)
North Carolina (1464)
North Dakota (9)
Northern California (5327)
Ohio (342)
Oklahoma (20)
Oregon (45)
Pennsylvania (2150)
Puerto Rico (25)
Rhode Island (43)
South America (1272)
South Carolina (70)
South Dakota (1)
Southern California (4343)
Tennessee (177)
Texas (1793)
United States (39492)
Utah (330)
Vermont (1)
Virginia (275)
Washington D.C. (76)
Washington State (927)
West Virginia (3)
Wisconsin (125)
Wyoming (2)
717,401 Results for "frederick national laboratory for cancer research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute
March 4, 2026
·
4 min read
Press Releases
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
March 4, 2026
·
15 min read
Press Releases
New Research: Rectal Cancer Incidence Rising After Decades of Decline as Colorectal Cancer Shifts Toward Younger Generations
March 2, 2026
·
5 min read
Press Releases
Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
January 29, 2026
·
3 min read
Press Releases
City of Hope Opens Only Cancer Specialty Hospital in Orange County, Calif., Advancing a National Model for Cancer Research and Treatment
November 20, 2025
·
7 min read
Press Releases
ELEPHAS BIOSCIENCES ANNOUNCES NEW RESEARCH PARTNERSHIP WITH THE UNIVERSITY OF LOUISVILLE TO STUDY ADVANCED STAGE SOLID CANCER TUMORS IN COLORECTAL, LIVER AND PANCREATIC CANCERS
February 24, 2026
·
3 min read
Press Releases
New Coalition of Leading Cancer Research Organizations Launched to Accelerate Early Detection of Deadly Cancers
February 4, 2026
·
9 min read
Press Releases
Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research
February 12, 2026
·
4 min read
Press Releases
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of Grant to Address Immunotherapy Resistance in Melanoma
January 23, 2026
·
3 min read
1 of 71,741
Next
